Epigenetic Priming with Decitabine Prior to Standard Induction Chemotherapy in Less-Than-Favorable Risk Acute Myelogenous Leukemia (AML).

Publication/Presentation Date

11-2009

Volume

114

Issue

22

Disciplines

Medicine and Health Sciences

Department(s)

Department of Medicine

Document Type

Article

Share

COinS